Skip to content

TROD MEDICAL

Active Public limited companyfounded 2013active for 13 yearsLenneke Marelaan 8, 1932 ZaventemKBO/BCE: BE 0536.848.874

Lifetime

13 annual accounts with figures on one time axis
peak of €436,533 in 2022
-€5,041▲ €1,761
lowest -€2.6m in 2015
-€5,338▲ €1,988
peak of €1.8m in 2014
-€103,444▼ €5,338
€370,836▼ 0.1%
peak of 1 FTE in 2014
-not published
Board14 names since 2013all names
4 directors and 3 others
Owners2 names in the annual accounts
22.86%
Documentsfilings and deeds
11-06-202650 days before the deadline
2025abbreviated format
Gross margin from -€6,801 to -€5,041Loss of €5,3381 director resigning, 4 reappointments 03-01

Key points

from the 2025 annual accounts

Equity

-€103,444
202020212022202320242025

Debts exceed assets in financial year 2025.

Losses

-€88,654 in three years
-75,9892023-7,3262024-5,3382025

Every financial year from 2023 to 2025 closed with a loss. 2023 was the heaviest.

Debts

€370,836 139% of the balance sheet
After one year 1%Within one year 99%

Of this, €368,229 falls due within a year.

Turnover not published in the abbreviated format

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,333 companies had the same profile as TROD MEDICAL has now. Each dot stands for 6 companies, two years later.

90.6%
were still trading
5.9%
stopped another way
2.8%
went bankrupt
  • Micro
  • 10 to 20 years old
  • negative equity
  • a small loss

Another 0.7% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,333 companies, not a prediction for TROD MEDICAL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director
Director
Director
Director
  • 22.86%score equity €1.6m (2025) · annual accounts 2025 of
Board & ownership

Recent changes

1 director resigning, 4 reappointments , (managing director), and reappointed · resigns · Discharge granted to · General meeting of 12-08-2024 · Gazette deed
Registered office moved from Brussels to Zaventem The registered office moved from Hertogsstraat 67 bus 6-1000 Brussel to Lenneke Marelaan 8 te 1932 Zaventem · Board meeting of 26-12-2023 · Gazette deed
Capital increase · Amendment of the articles 146,123 new shares · 106,538 new shares · General meeting of 27-10-2021 · Gazette deed
Registered office moved from Leuven to Brussels The registered office moved from Romeinse straat 10 (unit 15-17), 3001 Leuven (Heverlee) to Hertogstraat 67/6 te 1000 Brussel · Board meeting of 25-08-2021 · Gazette deed
All 47 events

Official details

Source: KBO
Status
Active since 22-07-2013Normal situation
Registered office
18 active companies are registered at this addressSource: KBO register, as of 20 November 2026.
Activity
Manufacture of computer, electronic and optical productsNACE 26600and 1 other2 activities on the establishment unitFrom the articles, 7 activities
Establishment unit
2.224.708.8561932 Zaventem, registered on 17-07-2013
Financial year end
31 December
Peppol
Reachable via Peppol
Company details

Annual accounts 2025

€267,393▼ 2.1%
Filing
Filed on 11-06-2026, 50 days before the end of the filing period
Financials

Insights on TROD MEDICAL

TROD MEDICAL files the abbreviated format. That format states no turnover. The gross margin rose from -€447,220 in 2013 to -€5,041 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about TROD MEDICAL

What is the company number of TROD MEDICAL?
The company number of TROD MEDICAL is 0536.848.874. The VAT number is the same number with BE in front: BE 0536.848.874.
Where is TROD MEDICAL based?
The registered office is at Lenneke Marelaan 8, 1932 Zaventem.Company details
What does TROD MEDICAL do?
According to the KBO register, the main activity of the establishment unit is manufacture of computer, electronic and optical products (NACE 26600). The KBO lists 1 more.
What is the legal form of TROD MEDICAL?
TROD MEDICAL is a public limited company (NV).
When was TROD MEDICAL founded?
TROD MEDICAL was founded on 22-07-2013.
Is TROD MEDICAL still active?
Yes, TROD MEDICAL is an active enterprise in the KBO register.
How many employees does TROD MEDICAL have?
TROD MEDICAL had an average of 0.3 full-time equivalents in financial year 2018, according to the filed annual accounts.Financials
What is the turnover of TROD MEDICAL?
The annual accounts for financial year 2025 state no turnover. The abbreviated format does not require it.
Is TROD MEDICAL profitable?
In financial year 2025, TROD MEDICAL made a loss of €5,338.
Where can I find the annual accounts of TROD MEDICAL?
TROD MEDICAL filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of TROD MEDICAL due?
TROD MEDICAL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.